Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. حسب Denis Mustafov (19137870)

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. حسب Denis Mustafov (19137870)

<i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model. حسب Robert L. Beckman I.V (22784303)

Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

الموضوعات:

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. حسب Hyung Suk Yang (20442438)

الموضوعات:

Inotodiol decreases clone formation in HCC cells. حسب Yushuang Xing (20636685)

"…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …"

Inotodiol decreases clone formation in HCC cells. حسب Yushuang Xing (20636685)

Trends in the burden of stroke attributed to smoking. حسب Jaber S. Alqahtani (8822396)

Summary of codes generated from MAXQDA software. حسب Awole Seid (3839965)

الموضوعات:

Schematic presentation of themes and categories. حسب Awole Seid (3839965)

الموضوعات:

Background characteristics of study participants. حسب Awole Seid (3839965)

الموضوعات:

Conceptual model derived from interpretations of findings. حسب Awole Seid (3839965)

الموضوعات:

Summary of key questions and follow-up probes used in the phenomenological study. حسب Awole Seid (3839965)

الموضوعات:

Dataset. حسب Awole Seid (3839965)

الموضوعات:

Side effects of vaccination that affected participants’ children. حسب Sara Saleh (6733619)

A summary of calibration standards (n = 3). حسب Ewa Paszkowska (21246702)

الموضوعات:

The observed MRM reactions. حسب Ewa Paszkowska (21246702)

الموضوعات:

Intra- and inter-day precision and accuracy. حسب Ewa Paszkowska (21246702)

الموضوعات:

Health inequalities in the burden of IBD among WCBA. حسب Jiefeng Zhao (9090305)

الموضوعات:

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. حسب Richard Junior Zapata Dongo (17912565)